Evaluation of the Relationship Between Biomarkers and Disease Severity in Patients with Community-Acquired Pneumonia

Abstract views: 100 / PDF downloads: 207





Biomarkers in Pneumonia, C-reactive protein, Community-acquired pneumonia, Disease Severity Assessment, Mean platelet volume


Objective: Biomarkers in community-acquired pneumonia (CAP) have the potential to facilitate clinical decisions by guiding the prediction of disease severity, treatment and prognosis. In this study, we evaluated the relationship of biomarkers with disease severity in patients with CAP.

Methods: 156 patients diagnosed with CAP were included in the study. Diagnosis of CAP was determined according to the Infectious Diseases Society of America (IDSA)/ American Thoracic Society(ATS) 2019 guidelines along with clinical findings. The CRB-65 scoring system was used to determine outpatient and hospitalized patients. Patient information was obtained retrospectively from their files. In these two patient groups; C-reactive protein (CRP), complete blood count (CBC) parameters, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/neutrophil ratio (MNR), lymphocyte/monocyte ratio (LMN), lymphocyte/CRP ratio (LCR), WBC/mean platelet volume ratio (WBC/MPV), CRP/MPV ratio, and MPV/PLT ratio were examined.

Results: Of the 156 patients included in the study, 72 were pneumonia patients receiving inpatient treatment (mean age 66.88±16.29) and 84 patients receiving outpatient treatment (mean age 51.57±16.68). Age was found to be statistically significant between the groups (p< 0.001). In the inpatient group; CRP, WBC, neutrophil, lymphocyte, monocyte, basophil, hemoglobin, hematocrit, MPV, NLR, PLR, LMR, NMR, LMR, LCR, WBC/MPV, and CRP/MPV were found to be significantly high (p<0.05). Parameters with diagnostic performance that may be helpful in distinguishing hospitalized patients with pneumonia are CRP/MPV (AUC:0.775, 95% CI:0.701-0.850), NLR (AUC:0.771, 95% CI:0.697-0.846) and CRP (AUC:0.758, 95% Cl:0.679-0.837).

Conclusion: NLR and CRP/MPV values, which can be measured easily and quickly together with CRP, can be used as additional tests to help distinguish patients with pneumonia requiring hospitalization.


Metrics Loading ...


Siljan WW, Holter JC, Michelsen AE, Nymo SH, Lauritzen T, Oppen K, Husebye E, Ueland T, Mollnes TE, Aukrust P, Heggelund H (2019) Inflammatory biomarkers are associatedwith aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study. ERJ Open Res. 5: 00014-2019. https://doi.org/10.1183/23120541.00014-2019

Wunderink RG, Waterer GW (2014) Community-acquired pneumonia. N Engl J Med. 370: 1863. https://doi.org/10.1056/nejmc1402692

Ewig S, Torres A (2011) Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality. Eur Respir J. 38: 253-260. https://doi.org/10.1183/09031936.00199810

Kruger S, Welte T (2012) Biomarkers in community-acquired pneumonia. Expert Rev Respir Med. 6: 203-214. https://doi.org/10.1586/ers.12.6

Viasus D, Del Rio-Pertuz G, Simonetti AF, Garcia-Vidal C, Acosta-Reyes J, Garavito A, Carratalà J (2016) Biomarkers for predicting short-term mortality incommunity-acquired pneumonia: a systematic review and meta-analysis. J Infect. 72: 273-282. https://doi.org/10.1016/j.jinf.2016.01.002

Christ-Crain M, Muller B (2007) Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators. Eur Respir J. 30: 556-573. https://doi.org/10.1183/09031936.00166106

Juvén T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, Eskola J, Saikku P, Ruuskanenet O (2000) Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 19:293-8. https://doi.org/10.1097/00006454-200004000-00006

Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken Jr GH (2004) Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 113:701-7. https://doi.org/10.1542/peds.113.4.701

Bekdas M, Goksugur SB, Sarac EG, Erkocoglu M, Demircioglu F (2014) Neutrophil/lymphocyte and C-reactive protein/mean platelet volume ratios in differentiating between viral and bacterial pneumonias and diagnosing early complications in children. Saudi Med J. 35:442-7.

Tan TQ, Mason EO Jr, Barson WJ, Wald ER, Schutze GE, Bradley JS, M Arditi M, L B Givner LB, Yogev R, Kim KS, Kaplan SL (1998) Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae. Pediatrics. 102:1369-75. https://doi.org/10.1542/peds.102.6.1369

Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Florence T, Kristoffersen KB, Burkhardt O, Welte T, Schroeder T, Nobre V, Wei L, Bucher HC, Annane D, Reinhart K, Falsey AR, Branche A, Damas P, Nijsten M, W de Lange D, Deliberato RO, Oliveira CF 21, Maravić-Stojković V, Verduri A, Beghé B, Cao B, Shehabi Y, Jensen J-US, Corti C, van Oers JAH, Beishuizen A, Girbes ARJ, Evelien de Jong ED, Briel M, Mueller B (2018) Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 18: 95-107. https://doi.org/10.1016/s1473-3099(17)30592-3

Esposito S, Di Gangi M, Cardinale F, Baraldi E, Corsini I, Da Dalt L, Tovo PA, Correra A, Villani A, Sacco O, Tenero L, Dones P, Gambino M, Zampiero A, Principi N; Ita-CAP Study Group (2016) Sensitivity and specificity of soluble triggering receptor expressed on myeloid cells-1, midregional proatrial natriuretic peptide and midregional proadrenomedullin for distinguishing etiology and to assess severity in community-acquired pneumonia. PLoS One. 11: e0163262. https://doi.org/10.1371/journal.pone.0163262

Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T; CAPNETZ Study Group (2008) Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J. 31: 349-355. https://doi.org/10.1183/09031936.00054507

Colak A, Zeytinli Aksit M, Toprak B, Yılmaz N (2020) Diagnostic values of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and procalcitonin in early diagnosis of bacteremia. Turk J Biochem. 4 5:57-64. https://doi.org/10.1515/tjb-2018-0484

İmre O. (2023) Evaluation of Mean Platelet Volüme, Platelet Distribution Width And Red Cell Distribution Width İn Bipolar Disorder. Van Med J. 30(2): 184-192 https://doi.org/10.5505/vtd.2023.14227

Yeaman MR (2014) Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol. 12: 426-37. https://doi.org/10.1038/nrmicro3269

Sun WX, Zhang JR, Cao ZG, Li Y, Wang RT (2014) A decreased mean platelet volüme is associated with stable and exacerbated asthma. Respiration. 88:31-7. https://doi.org/10.1159/000360296

Çiçek G, Açıkgöz SK, Yayla Ç, Kundi H, İleri M (2016) White blood cell count to mean platelet volume ratio: A novel and promising prognostic marker for st-segment elevation myocardial ınfarction. Cardiology J. 23:225-35. https://doi.org/10.5603/cj.a2016.0001

Güzel E.Ç, Fidan Ç, Güzel S, Paketçi C (2017) C-reactive protein (CRP)/mean platelet volume (MPV) ratio as a new biomarker for community-acquired pneumonia in children. Cukurova Med J. 42(3):451-458. https://doi.org/10.17826/cutf.323816

Menéndez R, Martínez R, Reyes S, Mensa J, Filella X, Marcos MA, Martínez A, Esquinas C, Ramirez P, Torres A (2009) Biomarkers improve mortality prediction by prognostic scales incommunity-acquired pneumonia. Thorax. 64:587-91. https://doi.org/10.1136/thx.2008.105312

Laukemann S, Kasper N, Kulkarni P, Steiner D, Rast AC, Kutz A, Felder S, Haubitz S, Faessler L, Huber A, Fux CA, Mueller B, Schuetz P (2015) Can we reduce negative blood cultures with clinical scores and blood markers? Results from an observational cohort study. Medicine. 94: e2264. https://doi.org/10.1097/md.0000000000002264

Karadag-Oncel E, Ozsurekci Y, Kara A, Karahan S, Cengiz AB, Ceyhan M (2013) The value of mean platelet volume in the determination of community acquired pneumonia in children. Ital J Pediatr. 39:16. https://doi.org/10.1186/1824-7288-39-16

Yavuzcan A, Cağlar M, Ustün Y, Dilbaz S, Ozdemir I, Yıldız E, Ozkara A, Selahattin Kumru S (2013) Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/ lymphocyte ratio in advanced stage endometriosis with endometrioma. J Turk Ger Gynecol Assoc. 14:210-5. https://doi.org/10.5152/jtgga.2013.55452

Öztürk ZA, Dag MS, Kuyumcu ME, Cam H, Yesil Y, Yilmaz N, Aydinli, Kadayifci A, Kepekci Y (2013) Could platelet indices be new biomarkers for inflammatory bowel diseases. Eur Rev Med Pharmacol Sci. 17:334-41

Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MSV, Go AS, Harrell Jr FE, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand J-L T, O’Donnell CJ, Smith Jr SC, F Wilson PW (2009) Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 119:2408-16. https://doi.org/10.1161/circulationaha.109.192278

Dehghani MR, Rezaei Y, Taghipour-Sani L (2015) White blood cell count to mean platelet volume ratio as a novel non-invasive marker predicting long-term outcomes in patients with non-ST elevation acute coronary syndrome. Cardiol J. 22.4:437-45. https://doi.org/10.5603/cj.a2015.0015




How to Cite

Yeşildağ, M., Özkan Bakdık , B., Balasar, B., & Eroğlu, E. (2024). Evaluation of the Relationship Between Biomarkers and Disease Severity in Patients with Community-Acquired Pneumonia. European Journal of Therapeutics. https://doi.org/10.58600/eurjther1976



Original Articles